The health value and cost of care for major depression

Value in Health

Volumn 12, Issue 1, 2009, Pages 65-72

  Watkins, Katherine E ^a   Burnam, M Audrey ^a   Orlando, Maria ^a   Escarce, José J ^a,b   Huskamp, Haiden A ^c   Goldman, Howard H ^d  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness analyses; Depression; Expert panel; Utility

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BILLING AND CLAIMS; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG EFFICACY; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEDICAL EXPERT; PATIENT CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; EXPERT TESTIMONY; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; PSYCHOTHERAPY, BRIEF; YOUNG ADULT;

EID: 58849103132     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00388.x     Document Type: Article

References (38)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC : IOM National Academy Press, 2001.
2. Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
3. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (Revision). Am J Psychiatry 2000 157 (Suppl. 4 S1 45.
4. Horvitz-Lennon M, Normand S-LT, Frank RG, et al. "Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes. Am J Psychiatry 2003 160 : 720 6.
5. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003 348 : 2635 45.
6. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001 58 : 55 61.
7. Institute of Medicine. Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-use Conditions. Washington, DC : National Academy Press, 2006.
8. Unutzer J, Katon W, Callahan CM, et al. Depression treatment in a sample of 1,801 depressed older adults in primary care. J Am Geriatr Soc 2003 51 : 505 14.
9. Gilbody SBP, Fletcher J, Richards D, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006 166 : 2314 21.
10. Katon WJ, Unutzer J, Simon G. Treatment of depression in primary care: where we are, where we can go. Med Care 2004 42 : 1153 7.
11. Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA 2003 290 : 57 65.
12. Vergouwen ACM, Bakker A, Katon WJ, et al. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 2003 64 : 1415 20.
13. Wells K, Sherbourne C, Schoenbaum M, et al. Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch Gen Psychiatry 2004 61 : 9.
14. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA/Arlington, VA : RAND & UCLA, 2001. MR-1269-DG-XII/RE.
15. Orlando M, Burnam MA, Watkins KE, et al. Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression. Med Decis Making (in press).
16. Morton SC, Kominski GF, Kahan JP. An examination of the resource-based relative value scale cross-specialty linkage method. Med Care 1994 32 : 25 39.
17. Blumenschein K, Johannesson M. Relationship between quality of life intruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998 80 : 189 94.
18. Rutten-van Molken MP, Custers F, van Doorslaer EK, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995 8 : 888 98.
19. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000 38 : 583 637.
20. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern Med 2001 234 : 345 60.
21. Depression Guidelines Panel. Depression in Primary Care, Vol. 1. Detection and Diagnosis. Rockville, MD : U.S. Department of Health and Human Services, Public Health Service, Agency for Health Research and Quality, 1993.
22. Depression Guidelines Panel. Depression in Primary Care, Vol. II. Treatment of Major Depression. Rockville, MD : U.S. Department of Health and Human Services, Public Health Service, Agency for Health Research and Quality, 1993.
23. Quitkin FM, Petkova E, Taylor B, et al. When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry 2003 160 : 734 40.
24. Elkin I, Shea MT, Watkins JT, et al. National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry 1989 46 : 972 82.
25. Lambert MJ, Davis MJ. Treatment for depression: what the research says. In : Reinecke MA, Davison MR, eds. Comparative Treatments of depression. New York, NY : Springer, 2002.
26. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy of psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997 54 : 1009 15.
27. Alegria M, Frank R, McGuire T. Managed care and systems cost-effectiveness: treatment for depression. Med Care 2005 43 : 1225 33.
28. Frank RG, McGuire TG, Normand ST, et al. The value of MH care at the system level: the case for treating depression. Health Aff (Millwood) 1999 18 : 71 88.
29. Kamlet MS, Paul N, Greenhouse J, et al. Cost utility analysis of maintenance treatment for recurrent depression. Control Clin Trials 1995 16 : 17 40.
30. Katon WJ, Schoenbaum M, Fan M-Y, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry 2005 62 : 1313 20.
31. Lave JR, Frank RG, Schulberg HC, et al. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 1998 55 : 645 51.
32. Pyne JM, Rost KM, Zhang M, et al. Cost-effectiveness of a primary care depression intervention. J Gen Intern Med 2003 18 : 432 41.
33. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001 286 : 1325 30.
34. Elkin I, Gibbons RD, Shea MT, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health treatment of depression collaborative research program. J Consult Clin Psychol 1995 63 : 841 7.
35. Geddes JR, Stuart MC, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003 361 : 653 61.
36. Shapiro DA, Rees A, Barham M, et al. Effects of treatment duration and severity of depression on the maintenance of gains following cognitive behavioral and psychodynamic interpersonal psychotherapy. J Consult Clin Psychol 1995 63 : 378 87.
37. Shekelle PG. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998 1998 338 : 8.
38. Shekelle PG, Chassin MR, Park RE. Assessing the predictive validity of the RAND/UCLA appropriateness method criteria for performing carotid endarterectomy. Int J Technol Assess Health Care 1998 14 : 21.